Effectiveness, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Optimization Study

Robert L. Findling; Lawrence D. Ginsberg; Rakesh Jain; Joseph Gao

doi:10.1089/cap.2008.0165

Effectiveness, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children With Attention-Deficit/Hyperactivity Disorder: An Open-Label, Dose-Optimization Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2008.0165 ◽

2009 ◽

Vol 19 (6) ◽

pp. 649-662 ◽

Cited By ~ 32

Author(s):

Robert L. Findling ◽

Lawrence D. Ginsberg ◽

Rakesh Jain ◽

Joseph Gao

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Dose Optimization ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder ◽

Optimization Study ◽

Label Dose

Download Full-text

A Dose-Optimization Study of the Efficacy, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years with Attention-Deficit/Hyperactivity Disorder

Paediatrics & Child Health ◽

10.1093/pch/14.suppl_a.16ab ◽

2009 ◽

Vol 14 (suppl_A) ◽

pp. 16A-17A

Author(s):

A Turgay ◽

L Ginsberg ◽

R Jain ◽

R Findling

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Dose Optimization ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder ◽

Optimization Study

Download Full-text

Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2020.0142 ◽

2021 ◽

Author(s):

Ann C. Childress ◽

Scott H. Kollins ◽

Andrew J. Cutler ◽

Andrea Marraffino ◽

Carolyn R. Sikes

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Dose Optimization ◽

Open Label ◽

Orally Disintegrating Tablet ◽

Hyperactivity Disorder ◽

Laboratory Classroom ◽

Label Dose ◽

Classroom Study

Download Full-text

4.7 EFFICACY OF METHYLPHENIDATE EXTENDED-RELEASE CHEWABLE TABLETS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: OPEN-LABEL, DOSE-OPTIMIZATION PERIOD OUTCOMES

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.202 ◽

2016 ◽

Vol 55 (10) ◽

pp. S164-S165

Author(s):

Sharon B. Wigal ◽

Ann Catherine Childress ◽

Sally Berry ◽

Heidi Belden ◽

Phillip B. Chappell ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Dose Optimization ◽

Open Label ◽

Hyperactivity Disorder ◽

Label Dose ◽

Chewable Tablets

Download Full-text

An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder

Psychiatry and Clinical Neurosciences ◽

10.1111/j.1440-1819.2010.02159.x ◽

2011 ◽

Vol 65 (1) ◽

pp. 55-63 ◽

Cited By ~ 14

Author(s):

Michihiro Takahashi ◽

Yasushi Takita ◽

Taro Goto ◽

Hironobu Ichikawa ◽

Kazuhiko Saito ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Dose Titration ◽

Open Label ◽

Hyperactivity Disorder ◽

Japanese Adults ◽

Label Dose

Download Full-text

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

CNS Drugs ◽

10.1007/s40263-017-0487-z ◽

2018 ◽

Vol 32 (1) ◽

pp. 85-95 ◽

Cited By ~ 7

Author(s):

David R. Coghill ◽

Tobias Banaschewski ◽

Caleb Bliss ◽

Brigitte Robertson ◽

Alessandro Zuddas

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Cognitive Function ◽

Children And Adolescents ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽

Hyperactivity Disorder

Download Full-text

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

CNS Drugs ◽

10.1007/s40263-018-0514-8 ◽

2018 ◽

Vol 32 (5) ◽

pp. 455-467 ◽

Cited By ~ 6

Author(s):

Tobias Banaschewski ◽

Mats Johnson ◽

Peter Nagy ◽

Isabel Hernández Otero ◽

César A. Soutullo ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Children And Adolescents ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Open Label Study ◽

Label Study ◽

Hyperactivity Disorder

Download Full-text

A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2011.0088 ◽

2013 ◽

Vol 23 (1) ◽

pp. 11-21 ◽

Cited By ~ 22

Author(s):

Robert L. Findling ◽

Andrew J. Cutler ◽

Keith Saylor ◽

Maria Gasior ◽

Mohamed Hamdani ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Effectiveness Trial ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text

Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2013.0077 ◽

2014 ◽

Vol 24 (4) ◽

pp. 210-217 ◽

Cited By ~ 3

Author(s):

Ann C. Childress ◽

Andrew J. Cutler ◽

Keith Saylor ◽

Maria Gasior ◽

Mohamed Hamdani ◽

...

Keyword(s):

Quality Of Life ◽

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder ◽

Perceived Quality Of Life ◽

Open Label Trial

Download Full-text

An Open-Label, Dose-Ranging Study of Atomoxetine in Children with Attention Deficit Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/10445460152595577 ◽

2001 ◽

Vol 11 (3) ◽

pp. 251-265 ◽

Cited By ~ 91

Author(s):

Thomas Spencer ◽

Joseph Biederman ◽

John Heiligenstein ◽

Timothy Wilens ◽

Douglas Faries ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Open Label ◽

Hyperactivity Disorder ◽

Label Dose ◽

Dose Ranging

Download Full-text

Open-Label Administration of Lisdexamfetamine Dimesylate Improves Executive Function Impairments and Symptoms of Attention-Deficit/Hyperactivity Disorder in Adults

Postgraduate Medicine ◽

10.3810/pgm.2010.09.2196 ◽

2010 ◽

Vol 122 (5) ◽

pp. 7-17 ◽

Cited By ~ 20

Author(s):

Thomas E. Brown ◽

Matthew Brams ◽

Joseph Gao ◽

Maria Gasior ◽

Ann Childress

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Executive Function ◽

Attention Deficit ◽

Open Label ◽

Lisdexamfetamine Dimesylate ◽

Hyperactivity Disorder

Download Full-text